TWiV 761: COVID-19 clinical update #64 with Dr. Daniel Griffin

In COVID-19 clinical update #64, Daniel Griffin covers new guidance from NY on day camps, mitigation and infection rates in schools, testing to sustain in person instruction, Moderna mRNA vaccine highly effective in adolescents, longer storage of Pfizer vaccine, FDA EUA for sotrovimab, and persistent illness in UK children. <div class="entry-content"> <p>Hosts: <a href="http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a></p> <p>Subscribe (free): <a href= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li>Guidance on <a href= "https://www.governor.ny.gov/sites/default/files/atoms/files/Child_Care_Daycamps_Detailed_Guidelines.pdf"> child camps and day care</a> (NY State)</li> <li>Mitigation and <a href= "https://www.medrxiv.org/content/10.1101/2021.05.19.21257467v1">schools</a> (medRxiv)</li> <li>Masks in <a href= "https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e1.htm">elementary schools</a> (MMWR)</li> <li>Testing to sustain <a href= "https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e2.htm?s_cid=mm7021e2_x"> in person instruction</a> (MMWR)</li> <li><a href= "https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-teencove-study-its-covid-19-vaccine"> TeenCOVE</a> results (Moderna)</li> <li>Pfizer/BioNTech vaccine <a href= "https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/downloads/storage-summary.pdf"> handling and storage</a> (CDC)</li> <li>EUA for <a href= "https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-an